Loading organizations...
§ Private Profile · 185 Alewife Brook Pkwy, Cambridge
Implicity is a technology company.
Implicity provides an AI-powered universal remote monitoring platform for patients with cardiac electronic implants and heart failure. The platform consolidates data from device manufacturers, leveraging data science, machine learning, and artificial intelligence. This technology streamlines clinical workflows, analyzes data, and manages alerts, improving outcomes and efficiency for cardiology practices.
Founded in 2016 by Dr. Arnaud Rosier, an electrophysiologist and health informatics doctor, Implicity addressed a critical gap. His clinical practice revealed fragmented, inefficient remote monitoring systems from vendors. He envisioned a unified solution to enhance patient care and vital prognosis, leading to the company's inception.
Implicity's platform serves healthcare providers, including electrophysiologists and their care teams, managing remote cardiac monitoring. Its vision focuses on transforming cardiology by leveraging data to enhance clinical operations and elevate patient care standards. Implicity aims to democratize efficient, comprehensive remote cardiac monitoring globally.
Implicity has raised $32.5M across 3 funding rounds.
Implicity has raised $32.5M in total across 3 funding rounds.
Implicity has raised $32.5M in total across 3 funding rounds.
Implicity's investors include Chahra Louafi, Delphine CARDI, Karista, BNP Paribas Développement, Serena Capital, XAnge.
Implicity has raised $32.5M across 3 funding rounds. Most recently, it raised $23.0M Series A in April 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2022 | $23M Series A | Chahra Louafi, Delphine Cardi | Karista, BNP Paribas Développement, Serena Capital, XAnge | Announced |
| Mar 14, 2019 | $4.5M Venture Round | — | — | Announced |
| Mar 1, 2019 | $5M Seed | — | Karista | Announced |
Implicity is a medical technology company specializing in AI-powered remote cardiac monitoring solutions. It builds a universal, alert-based platform designed to aggregate and analyze data from implantable cardiac devices (CIEDs) and other connected health devices to improve patient care and clinical workflow efficiency. The platform serves electrophysiologists, cardiology practices, and medical centers by simplifying remote monitoring, reducing false positives in arrhythmia detection, and automating billing compliance. Its solutions address the complexity and inefficiency of traditional remote cardiac monitoring, enabling better clinical outcomes and optimized productivity[1][2][4].
Founded in 2016 by Dr. Arnaud Rosier, an electrophysiologist who experienced firsthand the challenges of managing multiple disconnected remote monitoring systems, Implicity emerged to solve the problem of outdated and cumbersome remote cardiac monitoring tools. Dr. Rosier’s vision was to create a streamlined, AI-driven platform that would democratize remote monitoring and improve patient care by harnessing data science and machine learning. Early traction included developing FDA-cleared and CE-marked medical devices and securing partnerships, such as with Bayer HealthCare, to expand heart failure monitoring capabilities globally[1][3][4].
Implicity rides the growing trend of digital health and AI integration in cardiology, addressing the increasing demand for remote patient monitoring accelerated by healthcare digitization and the need for cost-effective chronic disease management. The timing is critical as remote cardiac monitoring has become a standard of care since 2015, and healthcare systems seek scalable, data-driven solutions to improve outcomes and reduce costs. By enabling predictive analytics and seamless data interoperability, Implicity influences the broader ecosystem by pushing forward preventive cardiology and empowering medical centers to adopt advanced digital tools[2][3][4].
Looking ahead, Implicity is poised to expand its AI capabilities and global footprint, particularly in heart failure management and integrated remote monitoring ecosystems. Trends such as increased adoption of connected health devices, regulatory support for digital health, and growing emphasis on personalized medicine will shape its journey. Its influence is likely to grow as it continues to democratize remote cardiac monitoring, improve clinical workflows, and contribute to preventive cardiology through advanced data science. This aligns with its founding mission to transform cardiology practice by unlocking the full power of data and AI-driven innovation[1][3][4].